Award information
Criteria
The winner of this award will be the company or organisation which has achieved the most significant breakthrough during the period 1 April 2024 to 31 March 2025.
This breakthrough could be a new discovery, departure or breakthrough in technology, a significant positive change in its financial position, or other breakthrough which has added significantly to the company’s or organisation’s fortunes.
2024 Winner
2024 Shortlist
- CRISPR Therapeutics AG
- Kooth plc
- Newron Pharmaceuticals SpA
- Santhera Pharmaceuticals
- Valneva SE
- Zealand Pharma A/S